BeiGene Ltd. (49B) — Capital Reinvestment Ratio

Latest as of March 2025: 2.64x

BeiGene Ltd. (49B) has a Capital Reinvestment Ratio of 2.64x as of March 2025, meaning it reinvests 3% of its operating cash flow (€44.08 Million) in capital expenditures (€116.41 Million). See BeiGene Ltd. (49B) balance sheet quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

2.64x

Capex / Operating Cash Flow

Operating Cash Flow

€44.08 Million

EUR

Capital Expenditures

€116.41 Million

EUR

Data as of

Mar 2025

Most recent filing

BeiGene Ltd. Capital Reinvestment Ratio (2017–2017)

This chart tracks BeiGene Ltd.'s Capital Reinvestment Ratio across 1 annual periods. Check 49B total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for BeiGene Ltd. (2017–2017)

Year-by-year Capital Reinvestment Ratio for BeiGene Ltd. from 2017 to 2017. For live market cap and broader valuation context, see how much is BeiGene Ltd. worth.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change
2017	3.64x	€12.75 Million	€46.37 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow